Author
R. Ketteler
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2019-2024 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 15 mutual co-author links7 papers
Recent·Most cited
Development of the ULK1-Recruiting Chimeras (ULKRECs) to enable proximity-induced and ULK1-dependent degradation of mitochondria
N. Zaman, N. Aley, V. Pingitore, D. L. Selwood, R. Ketteler
This paper introduces ULK1-Recruiting Chimeras (ULKRECs) that induce ULK1-dependent mitophagy, showing efficacy in Parkinson's fibroblasts independent of the PRKN/PINK axis.
bioRxiv · Apr 15, 2024 · PreprintCell Biology
Cardiac glycosides restore autophagy flux in an iPSC-derived neuronal model of WDR45 deficiency
A. Papandreou, N. Singh, L. Gianfrancesco, D. Budinger, K. Barwick, A. Agrotis, C. Luft, Y. Shao, A.-S. Lenaerts, A. Gregory, S. Y. Jeong, P. Hogarth, S. Hayflick, S. Barral, J. Kriston-Vizi, , R. Ketteler
This study identifies cardiac glycosides that restore autophagy and gene expression in an iPSC model of WDR45 deficiency, suggesting potential therapeutic applications for BPAN.
bioRxiv · Sep 13, 2023 · PreprintCell Biology
Proximity interactome of LC3B in normal growth conditions
M. Nollet, A. Agrotis, F. Michailidis, A. D. Dokal, V. Rajeeve, J. Burden, T. D. Nightingale, P. Cutillas, R. Ketteler, S. Kermorgant
The paper identifies 407 proteins interacting with LC3B in normal growth conditions using APEX2 proteomics, revealing novel interactors and expanding understanding of LC3B's roles beyond autophagy.
bioRxiv · Oct 8, 2021 · PreprintCell Biology
Modulation of endothelial organelle size as an antithrombotic strategy
F. Ferraro, J. Rodrigues Simoes Da Costa, J. Kriston-Vizi, R. Ketteler, D. F. Cutler
The paper identifies human-licenced drugs that reduce endothelial secretory granule size, offering potential antithrombotic compounds by modulating VWF adhesive activity.
bioRxiv · May 16, 2020Cell Biology
High-content screening for rare respiratory diseases: readthrough therapy in primary ciliary dyskinesia
D. D. H. Lee, D. Cardinale, E. Nigro, C. R. Butler, A. Rutman, M. R. Fassad, R. A. Hirst, D. Moulding, A. Agrotis, E. Forsythe, D. Peckham, E. Robson, C. M. Smith, S. Somavarapu, P. L. Beales, , C. O'Callaghan
The paper develops a high-content screening method using differentiated respiratory epithelium from PCD patients to evaluate readthrough therapies for rare respiratory diseases.
bioRxiv · Feb 28, 2020 · PreprintCell Biology
Signalling involving MET and FAK supports cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases
C. Zhang, S. R. Stockwell, M. Elbanna, R. Ketteler, J. Freeman, B. Al-Lazikani, S. Eccles, A. De Haven Brandon, F. Raynaud, A. Hayes, P. A. Clarke, P. Workman, S. Mittnacht
This study shows that MET/FAK signaling can activate CDK2 independently of CDK4/6, leading to cell division, and suggests targeting MET/FAK could enhance CDK4/6 inhibitor therapies.
bioRxiv · Apr 8, 2019Cancer Biology